KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

NovoCure (NVCR) Shares Outstanding (2016 - 2026)

NovoCure's Shares Outstanding history spans 13 years, with the latest figure at $115.8 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 3.89% to $115.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $115.8 million, a 3.89% increase, with the full-year FY2025 number at $112.5 million, up 3.66% from a year prior.
  • Shares Outstanding hit $115.8 million in Q1 2026 for NovoCure, up from $112.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for NVCR hit a ceiling of $115.8 million in Q1 2026 and a floor of $104.6 million in Q1 2022.
  • Historically, Shares Outstanding has averaged $108.3 million across 5 years, with a median of $107.6 million in 2024.
  • Biggest five-year swings in Shares Outstanding: increased 1.04% in 2022 and later increased 3.89% in 2026.
  • Tracing NVCR's Shares Outstanding over 5 years: stood at $105.0 million in 2022, then grew by 1.93% to $107.1 million in 2023, then increased by 1.35% to $108.5 million in 2024, then increased by 3.66% to $112.5 million in 2025, then rose by 2.96% to $115.8 million in 2026.
  • Business Quant data shows Shares Outstanding for NVCR at $115.8 million in Q1 2026, $112.5 million in Q4 2025, and $112.0 million in Q3 2025.